The activities of serum adenosine deaminase and xanthine oxidase enzymes in Behcet's disease

Clinica Chimica Acta

Volumn 325, Issue 1-2, 2002, Pages 133-138

  Söǧüt, Sadik ^a   Aydin, Erdinç ^b   Elyas, Halit ^c   Aksoy, Nurten ^d   Özyurt, Hüseyin ^a   Totan, Yüksel ^b   Akyol, Ömer ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

^d HARRAN UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Behcet's disease; Xanthine oxidase

Indexed keywords

ADENOSINE DEAMINASE; CELL MARKER; XANTHINE OXIDASE;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLICATION; CONTROLLED STUDY; ENZYME ACTIVITY; EYE INJURY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPECTROPHOTOMETRY; T LYMPHOCYTE ACTIVATION;

ADENOSINE DEAMINASE; ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; ENZYME TESTS; EYE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPECTRUM ANALYSIS; T-LYMPHOCYTES; XANTHINE OXIDASE;

EID: 0036843961     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00278-4     Document Type: Article

References (17)

1. Erem C., Uslu T., Deger O., Tosun M., Kavgaci H. Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events. Heart. 84:2000;208-209.
2. Lehner I. Immunopathogenesis of Behcet's disease. Ann. Med. Interne (Paris). 150:1999;483-487.
3. Yoshida T., Tanaka M., Sotomatsu A., Okamoto K., Hirai S. Serum of Behcet's disease enhances superoxide production of normal neutrophils. Free Radic. Res. 28:1998;39-44.
4. Galanti B., Nardiello S., Russo M., Fiorentino F. Increased lymphocyte adenosine deaminase in typhoid fever. Scand. J. Infect. Dis. 13:1981;47-50.
5. Mizushima Y, Inaba G, Mimura Y, et al. Guide for diagnosis of Behcet's disease, report of Behcet's Disease Research Committee, Japan. Ministry of Health and Welfare; 1987.
6. International Study Group for Behcet's Disease Criteria for diagnosis of Behcet's disease. Lancet. 335:1990;1078-1080.
7. Giusti G. Adenosine deaminase. Bergmeyer M.V. Methods of Enzymatic Analysis. 2nd Ed. 1974;1092-1098 Academic Press, New York.
8. Prajda N., Weber G. Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett. 59:1975;245-249.
9. Irmak M.K., Koltuksuz U., Kutlu N.O., Yagmurca M., Ozyurt H., Karaman A.et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with α-tocopherol in rat kidneys. Urol. Res. 29:2001;190-193.
10. Akyol O., Gokbulut I., Koksal N., Akin H., Ozyurt H., Yildirim Z. The activities of purine catabolizing enzymes in plasma and bronchial washing fluid in patients with lung cancer and pneumonia. Clin. Biochem. 34:2001;251-254.
11. Canbolat O., Akyol O., Kavutcu M., Isik A.U., Durak I. Serum adenosine deaminase and total superoxide dismutase activities before and after surgical removal of cancerous laryngeal tissue. J. Laryngol. Otol. 108:1994;849-851.
12. Molinos L., Fernandez R., Dominguez M.J., Reisgo C., Escudero C., Martinez J. Adenosine deaminase activity in the aetiological diagnosis of community-acquired pneumonia. Scan. J. Infect. Dis. 29:1997;287-290.
13. Kose K., Yazici C., Assioglu O. The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet's disease. Clin. Biochem. 34:2001;125-129.
14. Moss D.W., Handerson A.R. Enzymes. Burtis C.A., Ashwood E.R. Tietz fundamentals of Clinical Chemistry. 1996;297-300 Saunders, Philadelphia.
15. Turan B., Gallati H., Erdi H., Gurler A., Michel B.A., Villiger P.M. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease: soluble TNFR-75 as a biological marker of disease activity. J. Rheumatol. 24:1997;128-132.
16. Illei G.G., Lipsky P.E. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases. Curr. Opin. Immunol. 12:2000;712-718.
17. Desmedt M., Rottiers P., Dooms H., Fiers W., Grooten J. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J. Immunol. 160:1998;5300-5308.